Integrated in silico , in vitro , and in vivo exploration of Nephrolepis cordifolia for type 2 diabetes mellitus therapy
- 1 April 2026
- journal article
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 15 (2) , 217-229
Abstract
Introduction: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and pancreatic β-cell dysfunction, while current pharmacological therapies often show limited efficacy and adverse side effects. Nephrolepis cordifolia is a traditional medicine used to treat metabolic and inflammatory diseases. This study aimed to investigate the antidiabetic potential of N. cordifolia through an integrative approach of in silico, in vitro, and in vivo to elucidate the molecular mechanisms against T2DM. Methods: This study began with an in vitro assay to evaluate the ability of N. cordifolia to inhibit glucose release through amylolysis kinetics. In vivo experiments involved alloxan-induced diabetes in Wistar rats, which were administered extract doses of 200, 400, and 600 mg/kg to assess blood glucose levels and pancreatic histology. Meanwhile, in silico analysis identified genes expressed through GEO2R and performed molecular docking to explore potential antidiabetic mechanisms. Results: The ethyl acetate fraction of N. cordifolia effectively lowered glucose levels, showing the highest glucose dialysis retardation index (GDRI) value (82.56). In vivo tests demonstrated that the ethanol extract significantly reduced blood glucose levels (P < 0.05) and improved pancreatic histology at a dose of 600 mg/kg. Gene analysis revealed involvement in the diabetic cardiomyopathy pathway, with ellagic acid as the most active compound, exhibiting strong and stable binding to mitochondrial targets, including NDUFA9 and NDUFS4. Conclusion: N. cordifolia has potential as a natural product therapy candidate for the management of T2DM through specific molecular mechanisms.Keywords
This publication has 31 references indexed in Scilit:
- Traditional remedies from Aceh for diabetes mellitus treatment: Patterns of use in rural-urban areas in AcehClinical Epidemiology and Global Health, 2025
- Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategiesMedicine in Novel Technology and Devices, 2025
- Diabetes mellitus, the fastest growing global public health concern: Early detection should be focusedHealth Science Reports, 2024
- In-vitro antibacterial, antioxidant and anti-inflammatory and In-silico ADMET, molecular docking study on Hardwickia binata phytocompunds with potential inhibitor of skin cancer proteinIn Silico Pharmacology, 2023
- Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney diseaseInformatics in Medicine Unlocked, 2022
- In vivo antidiabetic and antioxidant activities of chloroform fraction of Nelsonia canescens Leaf in Alloxan-induced Diabetic RatsPharmacological Research - Modern Chinese Medicine, 2022
- Phytochemical Composition and in Vitro Antioxidant and Antidiabetic Activities of Nephrolepis auriculata (L.) Trimen: An Unexplored Ethnomedicinal Fern2022
- Genome-wide association studiesNature Reviews Methods Primers, 2021
- Metformin inhibits MAPK signaling and rescues pancreatic aquaporin 7 expression to induce insulin secretion in type 2 diabetes mellitusJournal of Biological Chemistry, 2021
- The power and limitations of gene expression pathway analyses toward predicting population response to environmental stressorsEvolutionary Applications, 2020